Genetics Generation Advancement Corp.

Equities

4160

TW0004160007

Biotechnology & Medical Research

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-05-05 pm EDT			5-day change	1st Jan Change
57.1 ^TWD	+7.33%		+3.44%	+46.79%

Mar. 25	Genetics Generation Advancement Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Genetics Generation Advancement Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Genetics Generation Advancement Corp. Proposes Cash Dividend for the Year Ended 31 December 2022

March 15, 2023 at 06:56 am EDT

Genetics Generation Advancement Corp. announced appropriations of earnings in cash dividends to shareholders is TWD 0.47754696 per share for the year ended 31 December 2022. Total amount of cash dividends to shareholders is TWD 11,579,089.

Latest news about Genetics Generation Advancement Corp.

Genetics Generation Advancement Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 25	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
Genetics Generation Advancement Corp. Proposes Cash Dividend for the Year Ended 31 December 2022	23-03-15	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
Genetics Generation Advancement Corp. Announces Cash Dividend, Payable on September 30, 2022	22-08-15	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-10	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12	CI
Genetics Generation Advancement Corp. Approves Appointment of John Chang as Chief Technical Officer	22-05-03	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-30	CI
Genetics Generation Advancement Corp. Announces Cash Dividend for the Period January 1, 2021 to December 31, 2021	22-03-17	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-10	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-12	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-13	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-29	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-12	CI
Genetics Generation Advancement Corp. Proposes Dividend Distribution, Payable on August 31, 2020	20-07-16	CI
Genetics Generation Advancement Corp. Announces Board Changes	20-06-11	CI
Genetics Generation Advancement Corp. Announces the Establishment of Audit Committee, Effective June 10, 2020	20-06-10	CI
Genetics Generation Advancement Corp. Announces Board Changes	20-06-10	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-13	CI
Genetics Generation Advancement Corp. Reports Earnings Results for the Full Year Ended December 31, 2019	20-03-29	CI
Genetics Generation Advancement Corp. Proposes Dividend Distribution	20-03-10	CI

Chart Genetics Generation Advancement Corp.

Duration

Period

Chart Genetics Generation Advancement Corp.

More charts

Company Profile

Genetics Generation Advancement Corp is a Taiwan-based company principally engaged in genetic testing business. The Company mainly provides genetic testing, molecular diagnostics, biotechnology, personalized medical related testing, biological information and health care services. The Company mainly serves in the areas of maternal-fetal precision, pediatric disease diagnosis, drug-associated diagnosis, non-invasive cancer detection and precision health management. The Company operates its businesses in domestic market and overseas markets.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
GENETICS GENERATION ADVANCEMENT CORP.	+46.79%	41.86M
EXACT SCIENCES CORPORATION	-14.37%	11.41B
IOVANCE BIOTHERAPEUTICS, INC.	+70.73%	3.81B
GUARDANT HEALTH, INC.	-29.39%	2.3B
BGI GENOMICS CO., LTD.	-12.90%	2.16B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+37.56%	1.19B
SEEGENE, INC.	-2.40%	760M
CAREDX, INC	-15.17%	506M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-34.29%	444M
CURIOX BIOSYSTEMS CO., LTD	+13.72%	339M

Bio Diagnostics & Testing